FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to the chemical-pharmaceutical industry and provides methods for treating acute myeloid leukemia (AML) in a patient aged over 65 using a medicament and the medicament itself, comprising a suspension of erythrocytes with an asparaginase encapsulated therein as an active component, where one dose of the suspension comprises 50 to 500 IU of encapsulated asparaginase per kg of body weight. In these methods of treating AML, one or more doses of the suspension are administered to the patient during the induction phase or during the treatment phase.
EFFECT: group of inventions makes it possible to administer an effective dose of L-asparaginase to patients aged over 65 without toxic effects, by encapsulating L-asparaginase in an erythrocyte suspension.
23 cl, 2 dwg, 2 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHORBOL ESTER COMPOSITIONS AND METHODS OF USING THEM FOR TREATING OR REDUCING DURATION OF CYTOPENIA | 2015 |
|
RU2730998C2 |
| METHOD OF TREATING RECURRENT ACUTE MYELOID LEUKAEMIA FOLLOWING TRANSPLANTATION OF ALLOGENIC HAEMOPOIETIC STEM CELLS | 2013 |
|
RU2538799C1 |
| CYTARABINE CONJUGATES FOR TREATING CANCER | 2016 |
|
RU2708672C1 |
| METHOD OF TREATING CANCER IN A MAMMAL, INCLUDING A HUMAN, USING METHIONINE AND ASPARAGINE DEPLETION | 2017 |
|
RU2733389C2 |
| METHOD FOR THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA FROM PROGENITOR B-CELLS WITH REARRANGEMENTS IN THE KMT2A GENE IN CHILDREN OF THE FIRST YEAR OF LIFE | 2022 |
|
RU2797687C1 |
| METHOD OF ASSESSING MINIMAL RESIDUAL DISEASE (MRD) BY MULTICOLOR FLOW CYTOMETRY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN THE POST-INDUCTION PHASE OF TREATMENT | 2022 |
|
RU2802131C1 |
| COMBINED THERAPY FOR TREATMENT OF ACUTE LEUKEMIA AND MYELODISPLASTIC SYNDROME | 2002 |
|
RU2338535C2 |
| TREATMENT METHOD FOR ACUTE MYELOID LEUKEMIA | 2020 |
|
RU2812782C2 |
| PREPARATIONS OF POLYALKYLENE OXIDE-ASPARAGINASE AND METHODS FOR THEIR PREPARATION AND APPLICATION | 2017 |
|
RU2758796C2 |
| METHOD OF TREATMENT BY APPLICATION OF COMBINED THERAPY | 2010 |
|
RU2543348C2 |
